Institutional & Family Asset Management’s Heron Therapeutics HRTX Stock Holding History

Institutional & Family Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-50	Closed	-$1K	–	854
2019 Q2	$1K	Hold	50	–	–	﹤0.01%	803
2019 Q1	$1K	Hold	50	–	–	﹤0.01%	793
2018 Q4	$1K	Hold	50	–	–	﹤0.01%	771
2018 Q3	$2K	Hold	50	–	–	﹤0.01%	740
2018 Q2	$2K	Hold	50	–	–	﹤0.01%	724
2018 Q1	$1K	Buy	+50	New	+$1.13K	﹤0.01%	791

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Institutional & Family Asset Management's HRTX Position: Q3 2019 in Review

Institutional & Family Asset Management sold out of Heron Therapeutics (HRTX) in Q3 2019, closing a stake of 50 shares — an estimated $1K sold.

Institutional & Family Asset Management first reported a position in HRTX in Q1 2018 and held it in 6 quarters. The position peaked at $2K in Q3 2018. 180 funds tracked by Wall St. Rank hold HRTX as of Q3 2019.

Institutional & Family Asset Management reported no remaining Heron Therapeutics position as of Q3 2019 after selling out during the quarter.
Institutional & Family Asset Management sold 50 Heron Therapeutics shares in Q3 2019, an estimated $1K.
Institutional & Family Asset Management first reported a position in Heron Therapeutics in Q1 2018 and held it in 6 quarters.
Institutional & Family Asset Management's Heron Therapeutics position peaked at $2K in Q3 2018.
180 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2019.

Based on Institutional & Family Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.